8-K//Current report
Adaptimmune Therapeutics PLC 8-K
Accession 0001558370-25-011616
$ADAPCIK 0001621227operating
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:30 PM ET
Size
205.8 KB
Accession
0001558370-25-011616
Documents
- 8-Kadap-20250815x8k.htmPrimary
8-K
- EX-10.1adap-20250815xex10d1.htm
EX-10.1
- EX-101.SCHadap-20250815.xsd
EX-101.SCH
- EX-101.LABadap-20250815_lab.xml
EX-101.LAB
- EX-101.PREadap-20250815_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001558370-25-011616-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLadap-20250815x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001621227
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:30 PM ET
- Size
- 205.8 KB